Zhejiang Hisun BiomaterialsLtd Future Growth
Future criteria checks 5/6
Zhejiang Hisun BiomaterialsLtd is forecast to grow earnings and revenue by 31.1% and 26.9% per annum respectively. EPS is expected to grow by 31.1% per annum. Return on equity is forecast to be 5.2% in 3 years.
Key information
31.1%
Earnings growth rate
31.1%
EPS growth rate
| Chemicals earnings growth | 33.4% |
| Revenue growth rate | 26.9% |
| Future return on equity | 5.2% |
| Analyst coverage | Low |
| Last updated | 21 Sep 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,619 | 102 | N/A | 200 | 1 |
| 12/31/2025 | 1,136 | 68 | N/A | 259 | 1 |
| 12/31/2024 | 916 | 52 | N/A | 76 | 1 |
| 6/30/2024 | 851 | 49 | -175 | 90 | N/A |
| 3/31/2024 | 802 | 46 | -136 | 103 | N/A |
| 12/31/2023 | 753 | 44 | -51 | 163 | N/A |
| 9/30/2023 | 677 | 42 | -115 | 139 | N/A |
| 6/30/2023 | 636 | 45 | -118 | 132 | N/A |
| 3/31/2023 | 573 | 41 | -77 | 129 | N/A |
| 12/31/2022 | 605 | 47 | -89 | 136 | N/A |
| 9/30/2022 | 639 | 49 | -79 | 167 | N/A |
| 6/30/2022 | 622 | 35 | -82 | 181 | N/A |
| 3/31/2022 | 635 | 31 | -215 | 131 | N/A |
| 12/31/2021 | 585 | 35 | -238 | 71 | N/A |
| 12/31/2020 | 263 | 30 | -169 | 29 | N/A |
| 12/31/2019 | 232 | 10 | -86 | 30 | N/A |
| 12/31/2018 | 228 | 9 | -7 | 31 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688203's forecast earnings growth (31.1% per year) is above the savings rate (2.9%).
Earnings vs Market: 688203's earnings (31.1% per year) are forecast to grow faster than the CN market (23.3% per year).
High Growth Earnings: 688203's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688203's revenue (26.9% per year) is forecast to grow faster than the CN market (13.2% per year).
High Growth Revenue: 688203's revenue (26.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688203's Return on Equity is forecast to be low in 3 years time (5.2%).